Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02762968
Other study ID # MTI2016-CS02
Secondary ID
Status Completed
Phase N/A
First received May 3, 2016
Last updated January 27, 2017
Start date April 2016
Est. completion date August 2016

Study information

Verified date January 2017
Source Metabolic Technologies Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will determine whether acute ingestion of a probiotic combined with beta-hydroxy-beta-methylbutyrate (HMB) can enhance immune and digestive function in soldiers during 8-weeks of advanced infantry training.


Description:

Up to sixty soldiers from an elite infantry unit will perform a parallel design investigation. Soldiers will be randomly assigned to one of four groups. Group 1 will consume the probiotic plus HMB, group 2 will consume HMB only, group 3 will consume only the probiotic, and group 4 will consume only placebo. All four groups will be garrisoned together, eat the same meals, and perform the same activity. All groups will be tested before as well as after an 8-week advanced infantry training program. During each testing session resting blood samples will be obtained to assess cytokine, inflammatory, and muscle damage markers. Additionally, questionnaires will be used to determine digestive health. Anthropometric, performance, and muscle volume measures will also be assessed prior to and immediately following the supplementation and training protocol.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date August 2016
Est. primary completion date July 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- 18 years of age

- Member of the same unit of the IDF

Exclusion Criteria:

- Current use of dietary supplements

- Current chronic use of medications

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Placebo
Placebo capsules similar to the experimental treatments.
HMB
Capsules containing calcium HMB.
BC30
Bacillus Coagulans GBI-30, 6086 (BC30) mixed in water.

Locations

Country Name City State
Israel Israel Beersheva

Sponsors (2)

Lead Sponsor Collaborator
Metabolic Technologies Inc. University of Central Florida

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maintenance of Immune function Immune function assessed by blood biochemical analysis (ELISA). 8 weeks
Secondary Maintenance of Digestive Function Digestive function assessed by questionnaire. 8 Weeks
Secondary Maintenance of Muscle Volume Muscle volume will be assessed using a 3.0 Tesla whole-body imager (cubic centimeter) 8 Weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04533984 - Fracture Recovery for Returning to Duty (Teriparatide STRONG) Phase 4